Berkeley Capital Partners’s GSK GSK Stock Holding History

Berkeley Capital Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,614	Closed	-$271K	–	120
2019 Q4	$271K	Sell	4,614 -1,280	-22%	-$71.2K	0.14%	118
2019 Q3	$314K	Sell	5,894 -1,009	-15%	-$51.9K	0.17%	107
2019 Q2	$345K	Sell	6,903 -1,607	-19%	-$80.6K	0.16%	103
2019 Q1	$445K	Buy	8,510 +604	+8%	+$30.2K	0.22%	88
2018 Q4	$378K	Buy	+7,906	New	+$389K	0.21%	87
2018 Q3	–	Sell	-6,768	Closed	-$341K	–	117
2018 Q2	$341K	Sell	6,768 -1,530	-18%	-$77.1K	0.2%	92
2018 Q1	$405K	Sell	8,298 -1,646	-17%	-$76.7K	0.23%	88
2017 Q4	$441K	Sell	9,944 -337	-3%	-$15.6K	0.29%	83
2017 Q3	$522K	Buy	10,281 +4,365	+74%	+$221K	0.35%	77
2017 Q2	$319K	Sell	5,916 -737	-11%	-$39.3K	0.22%	92
2017 Q1	$351K	Sell	6,653 -4,080	-38%	-$207K	0.24%	90
2016 Q4	$517K	Buy	10,733 +4,618	+76%	+$228K	0.37%	67
2016 Q3	$330K	Buy	6,115 +82	+1%	+$4.5K	0.24%	83
2016 Q2	$327K	Sell	6,033 -2,943	-33%	-$155K	0.23%	83
2016 Q1	$455K	Buy	8,976 +3,510	+64%	+$175K	0.33%	63
2015 Q4	$276K	Buy	+5,466	New	+$279K	0.22%	84

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Berkeley Capital Partners's GSK Position: Q1 2020 in Review

Berkeley Capital Partners sold out of GSK (GSK) in Q1 2020, closing a stake of 4,614 shares — an estimated $271K sold.

Berkeley Capital Partners first reported a position in GSK in Q4 2015 and held it in 16 quarters. The position peaked at $522K in Q3 2017. 818 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Berkeley Capital Partners reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Berkeley Capital Partners sold 4,614 GSK shares in Q1 2020, an estimated $271K.
Berkeley Capital Partners first reported a position in GSK in Q4 2015 and held it in 16 quarters.
Berkeley Capital Partners's GSK position peaked at $522K in Q3 2017.
818 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Berkeley Capital Partners's 13F filing for Q1 2020, filed 21 Apr 2020.